These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

720 related articles for article (PubMed ID: 31679519)

  • 1. STING: a master regulator in the cancer-immunity cycle.
    Zhu Y; An X; Zhang X; Qiao Y; Zheng T; Li X
    Mol Cancer; 2019 Nov; 18(1):152. PubMed ID: 31679519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Pathways: Targeting the Stimulator of Interferon Genes (STING) in the Immunotherapy of Cancer.
    Corrales L; Gajewski TF
    Clin Cancer Res; 2015 Nov; 21(21):4774-9. PubMed ID: 26373573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. cGAS-STING pathway mediates activation of dendritic cell sensing of immunogenic tumors.
    Li G; Zhao X; Zheng Z; Zhang H; Wu Y; Shen Y; Chen Q
    Cell Mol Life Sci; 2024 Mar; 81(1):149. PubMed ID: 38512518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive elaboration of the cGAS-STING signaling axis in cancer development and immunotherapy.
    Zheng J; Mo J; Zhu T; Zhuo W; Yi Y; Hu S; Yin J; Zhang W; Zhou H; Liu Z
    Mol Cancer; 2020 Aug; 19(1):133. PubMed ID: 32854711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of the Phagocytic Receptor MerTK on Tumor-Associated Macrophages Enhances P2X7R-Dependent STING Activation by Tumor-Derived cGAMP.
    Zhou Y; Fei M; Zhang G; Liang WC; Lin W; Wu Y; Piskol R; Ridgway J; McNamara E; Huang H; Zhang J; Oh J; Patel JM; Jakubiak D; Lau J; Blackwood B; Bravo DD; Shi Y; Wang J; Hu HM; Lee WP; Jesudason R; Sangaraju D; Modrusan Z; Anderson KR; Warming S; Roose-Girma M; Yan M
    Immunity; 2020 Feb; 52(2):357-373.e9. PubMed ID: 32049051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insight into the dichotomous regulation of STING activation in immunotherapy.
    Hu Z; Yang Y; Fang L; Zhou J; Zhang H
    Immunopharmacol Immunotoxicol; 2021 Apr; 43(2):126-137. PubMed ID: 33618600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of Stimulation of Interferon Genes (STING) Signal and Cancer Immunotherapy.
    Luo K; Li N; Ye W; Gao H; Luo X; Cheng B
    Molecules; 2022 Jul; 27(14):. PubMed ID: 35889509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cGas-Sting Signaling Pathway Is Required for the Innate Immune Response Against Ectromelia Virus.
    Cheng WY; He XB; Jia HJ; Chen GH; Jin QW; Long ZL; Jing ZZ
    Front Immunol; 2018; 9():1297. PubMed ID: 29963044
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Costa Franco MM; Marim F; Guimarães ES; Assis NRG; Cerqueira DM; Alves-Silva J; Harms J; Splitter G; Smith J; Kanneganti TD; de Queiroz NMGP; Gutman D; Barber GN; Oliveira SC
    J Immunol; 2018 Jan; 200(2):607-622. PubMed ID: 29203515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A nanoparticle-incorporated STING activator enhances antitumor immunity in PD-L1-insensitive models of triple-negative breast cancer.
    Cheng N; Watkins-Schulz R; Junkins RD; David CN; Johnson BM; Montgomery SA; Peine KJ; Darr DB; Yuan H; McKinnon KP; Liu Q; Miao L; Huang L; Bachelder EM; Ainslie KM; Ting JP
    JCI Insight; 2018 Nov; 3(22):. PubMed ID: 30429378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STING Signaling in Cancer Cells: Important or Not?
    Sokolowska O; Nowis D
    Arch Immunol Ther Exp (Warsz); 2018 Apr; 66(2):125-132. PubMed ID: 28748479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diminished Innate Antiviral Response to Adenovirus Vectors in cGAS/STING-Deficient Mice Minimally Impacts Adaptive Immunity.
    Anghelina D; Lam E; Falck-Pedersen E
    J Virol; 2016 Jul; 90(13):5915-27. PubMed ID: 27076643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity.
    Demaria O; De Gassart A; Coso S; Gestermann N; Di Domizio J; Flatz L; Gaide O; Michielin O; Hwu P; Petrova TV; Martinon F; Modlin RL; Speiser DE; Gilliet M
    Proc Natl Acad Sci U S A; 2015 Dec; 112(50):15408-13. PubMed ID: 26607445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic regulation of cGAS and STING expression in cancer.
    Zhao C; Guo S; Ge S
    Int Immunopharmacol; 2024 Sep; 138():112556. PubMed ID: 38936059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. cGAS-STING signaling in cancer immunity and immunotherapy.
    Du H; Xu T; Cui M
    Biomed Pharmacother; 2021 Jan; 133():110972. PubMed ID: 33254021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activating cGAS-STING pathway for the optimal effect of cancer immunotherapy.
    Li A; Yi M; Qin S; Song Y; Chu Q; Wu K
    J Hematol Oncol; 2019 Apr; 12(1):35. PubMed ID: 30935414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive feedback regulation of type I interferon by the interferon-stimulated gene STING.
    Ma F; Li B; Yu Y; Iyer SS; Sun M; Cheng G
    EMBO Rep; 2015 Feb; 16(2):202-12. PubMed ID: 25572843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacterial-induced cell fusion is a danger signal triggering cGAS-STING pathway via micronuclei formation.
    Ku JWK; Chen Y; Lim BJW; Gasser S; Crasta KC; Gan YH
    Proc Natl Acad Sci U S A; 2020 Jul; 117(27):15923-15934. PubMed ID: 32571920
    [No Abstract]   [Full Text] [Related]  

  • 19. Function and Molecular Mechanism of the DNA Damage Response in Immunity and Cancer Immunotherapy.
    Ye Z; Shi Y; Lees-Miller SP; Tainer JA
    Front Immunol; 2021; 12():797880. PubMed ID: 34970273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting STING for cancer immunotherapy: From mechanisms to translation.
    Huang R; Ning Q; Zhao J; Zhao X; Zeng L; Yi Y; Tang S
    Int Immunopharmacol; 2022 Dec; 113(Pt A):109304. PubMed ID: 36252492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.